For your Class III IVD devices that are considered to be high-risk and for which there is no legally marketed predicate device, we help demonstrate that the device is safe and effective for its intended use.
Demonstrating the safety and efficacy of your device
Our on-staff regulatory experts understand the unique landscape in medical device and diagnostics. With proven expertise in all manner of studies— PMA, 510k equivalence, and de novo submissions—we are prepared to answer your FDA-related questions, review and support submissions.
Regulatory pathways
No matter your therapeutic area, we can provide regulatory strategies, manage pre-submission meetings with regulatory bodies, and assist with regulatory pathways.
IDE preparation including pre-IDE meetings.
For your Class II and III IVD devices in the United States, we can support your Premarket Notification (510(k)) to the US Food and Drug Administration (FDA) that demonstrates substantial equivalence.
For your low to moderate-risk Class II devices that do not meet the criteria for the 510(k) pathway, but still require regulatory clearance or approval.
For your IVD devices planned for the European Union. The IVDR framework that replaces the In-Vitro Diagnostic Directive (98/79/EC) introduces new requirements for the marketing and labeling of IVD devices, as well as new performance and quality standards.
Let's discuss your project
Contact our pharma solutions experts to design a custom program to accommodate the needs of your study.
Let's discuss your next project
Connect with our team of experts today.
Expertise
Expertise
- Site map
- Privacy Notices
- Terms
- Contact us
- Language assistance / non-discrimination
- Asistencia de idiomas / Aviso de no discriminación
- 語言協助 / 不歧視通知
- Accessibility
-
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.